# ETON (Eton Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Eton Pharmaceuticals, Inc. reported $141.1M in revenue and net income of $49.86M for the trailing twelve months ended September 30, 2026 (up 157.9% year over year), with a 69.2% gross margin and a 28.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/ETON
- Markdown: https://convexityos.com/fundamentals/ETON.md
- SEC CIK: 0001710340
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:23 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001710340&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $141.1M | +157.9% YoY |
| Operating Income | TTM | $40.69M | 28.8% margin |
| Net Income | TTM | $49.86M | 35.3% net margin |
| Diluted EPS | TTM | $1.50 | Split-adjusted |
| Free Cash Flow | TTM | $38.22M | 27.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $55.63M | Total debt: $24.33M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $79.95M | $39.01M | $31.64M | $21.25M | $21.83M | $39K | $959K | -- |
| Cost of Revenue | $37.21M | $15.60M | $10.58M | $6.93M | $2.83M | $436K | $453K | -- |
| **Gross Profit** | $42.74M | $23.41M | $21.06M | $14.32M | $19.00M | -$397K | $506K | -- |
| Research & Development | $7.76M | $3.25M | $3.32M | $4.00M | $6.24M | $14.10M | $11.55M | $5.63M |
| Total Operating Expenses | $43.58M | $26.01M | $22.25M | $22.58M | $20.50M | $26.71M | $19.11M | $10.32M |
| **Operating Income** | -$844K | -$2.60M | -$1.19M | -$8.26M | -$1.50M | -$27.11M | -$18.60M | -$10.32M |
| **EBITDA** | $3.20M | -$1.45M | -$291K | -$8.19M | -$1.34M | -$26.76M | -$18.32M | -$10.26M |
| Interest Expense | $4.78M | $2.00M | $1.06M | $955K | $1.04M | $884K | $98K | -- |
| Income Before Tax | -$4.56M | -$3.81M | -$689K | -$9.02M | -$1.96M | -$27.97M | -$18.32M | -$12.74M |
| Income Tax Expense | $43K | $15K | $247K | $0 | $0 | -- | -- | -- |
| **Net Income** | -$4.60M | -$3.82M | -$936K | -$9.02M | -$1.96M | -$27.97M | -$18.32M | -$12.74M |
| Basic EPS | -$0.17 | -$0.15 | -$0.04 | -$0.36 | -$0.08 | -$1.33 | -$1.03 | -$5.80 |
| **Diluted EPS** | -- | -- | -- | -- | -$0.08 | -$1.33 | -$1.03 | -$5.80 |
| Basic Shares Outstanding | 26.9M | 25.9M | 25.6M | 25.1M | 25.2M | 21.0M | 17.8M | 6.4M |
| Diluted Shares Outstanding | -- | -- | -- | -- | 25.2M | 21.0M | 17.8M | 6.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $57.92M | $37.59M | $24.27M | $21.28M | $22.46M | $18.93M | $17.28M | $11.65M |
| Cost of Revenue | $13.62M | $12.18M | $9.53M | $8.18M | $14.60M | $7.00M | $7.42M | $5.17M |
| **Gross Profit** | $44.30M | $25.41M | $14.73M | $13.10M | $7.86M | $11.92M | $9.86M | $6.48M |
| Research & Development | $5.27M | $993K | $1.88M | $1.78M | $1.11M | $3.71M | $1.16M | -$871K |
| Total Operating Expenses | $21.29M | $12.62M | $12.32M | $10.64M | $9.22M | $13.40M | $10.33M | $5.85M |
| **Operating Income** | $23.01M | $12.79M | $2.41M | $2.46M | -$1.36M | -$1.48M | -$470K | $629K |
| **EBITDA** | $24.46M | $14.18M | $3.54M | $3.48M | -$354K | -$470K | $543K | $984K |
| Interest Expense | -- | $1.01M | $1.14M | -- | $1.21M | $1.20M | $1.16M | $1.51M |
| Income Before Tax | $22.36M | $11.72M | $1.57M | $1.41M | -$1.96M | -$2.52M | -$1.50M | -$511K |
| Income Tax Expense | -$12.89M | $140K | $20K | -$69K | -$28K | $66K | $74K | $87K |
| **Net Income** | $35.25M | $11.58M | $1.55M | $1.48M | -$1.93M | -$2.58M | -$1.57M | -$598K |
| Basic EPS | $1.23 | $0.42 | $0.06 | -- | -$0.07 | -$0.10 | -$0.06 | -- |
| **Diluted EPS** | $1.06 | $0.35 | $0.05 | -- | -$0.07 | -$0.10 | -$0.06 | -- |
| Basic Shares Outstanding | 28.7M | 27.6M | 27.3M | -- | 26.9M | 26.9M | 26.9M | -- |
| Diluted Shares Outstanding | 33.3M | 32.8M | 31.5M | -- | 26.9M | 26.9M | 26.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.94M | $14.94M | $21.39M | $16.30M | $14.41M | $21.30M | $12.07M | $26.73M | $13.16M |
| **Cash & Short-Term Investments** | $25.94M | $14.94M | $21.39M | $16.30M | $14.41M | $21.30M | $12.07M | $26.73M | $13.16M |
| Accounts Receivable, Net | $11.76M | $5.36M | $3.41M | $1.85M | $5.47M | $48K | $473K | -- | -- |
| Inventory | $15.42M | $15.23M | $911K | $557K | $550K | $1.24M | $380K | -- | -- |
| **Total Current Assets** | $60.58M | $41.02M | $26.84M | $20.00M | $23.60M | $24.70M | $15.01M | $27.50M | $13.29M |
| Property, Plant & Equipment, Net | $326K | $34K | $58K | $72K | $115K | $811K | $1.12M | $773K | $119K |
| Intangible Assets | $30.88M | $34.88M | $4.74M | $4.75M | $3.62M | $575K | $725K | -- | -- |
| Other Non-Current Assets | $19K | $12K | $12K | $12K | $21K | $40K | $61K | $52K | $32K |
| **Total Non-Current Assets** | $31.53M | $35.10M | $4.90M | $5.03M | $3.86M | $1.62M | $2.06M | $825K | $151K |
| **Total Assets** | $92.11M | $76.12M | $31.74M | $25.03M | $27.46M | $26.32M | $17.07M | $28.33M | $13.44M |
| Accounts Payable | $10.98M | $4.17M | $1.85M | $1.77M | $1.77M | $2.34M | $575K | $1.42M | $539K |
| Short-Term Debt | $8.79M | $0 | $5.38M | $1.03M | $1.42M | -- | -- | -- | -- |
| **Total Current Liabilities** | $38.49M | $19.95M | $16.24M | $6.46M | $4.56M | $3.79M | $1.96M | $2.02M | $793K |
| Long-Term Debt | $21.77M | $29.81M | -- | $4.35M | $3.84M | $6.53M | $4.54M | -- | -- |
| Other Non-Current Liabilities | $5.24M | $1.83M | $0 | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $27.47M | $31.75M | $22K | $5.49M | $5.28M | $6.86M | $4.56M | $0 | $520K |
| **Total Liabilities** | $65.96M | $51.70M | $16.26M | $11.95M | $9.84M | $10.66M | $6.52M | $2.02M | $1.31M |
| **Total Debt (incl. Leases)** | $31.08M | $29.99M | $5.46M | $5.57M | $5.28M | $6.63M | $4.56M | -- | -- |
| Common Stock | $27K | $27K | $26K | $25K | $25K | $24K | $18K | $18K | $6.0K |
| Retained Earnings | -$112.5M | -$107.9M | -$104.1M | -$103.1M | -$94.11M | -$92.16M | -$64.19M | -$45.87M | -$8.64M |
| **Total Stockholders' Equity** | $26.15M | $24.43M | $15.48M | $13.08M | $17.63M | $17.63M | $10.55M | $26.30M | -$6.87M |
| Total Equity | $26.15M | $24.43M | $15.48M | $13.08M | $17.63M | $17.63M | $10.55M | $26.30M | -$6.87M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $55.63M | $26.84M | $19.66M | $25.94M | $37.12M | $25.38M | $17.42M | $14.94M |
| **Cash & Short-Term Investments** | $55.63M | $26.84M | $19.66M | $25.94M | $37.12M | $25.38M | $17.42M | $14.94M |
| Accounts Receivable, Net | $26.43M | $24.89M | $13.41M | $11.76M | $13.08M | $14.45M | $16.40M | $5.36M |
| Inventory | $11.08M | $10.14M | $14.47M | $15.42M | $16.86M | $23.79M | $13.62M | $15.23M |
| **Total Current Assets** | $96.78M | $68.60M | $53.24M | $60.58M | $72.00M | $68.44M | $49.96M | $41.02M |
| Property, Plant & Equipment, Net | $338K | $352K | $372K | $326K | $294K | $18K | $22K | $34K |
| Intangible Assets | $44.28M | $45.68M | $43.74M | $30.88M | $31.88M | $32.88M | $33.88M | $34.88M |
| Other Non-Current Assets | $64K | $64K | $54K | $19K | $19K | $12K | $12K | $12K |
| **Total Non-Current Assets** | $60.49M | $47.21M | $44.47M | $31.53M | $32.51M | $33.23M | $34.07M | $35.10M |
| **Total Assets** | $157.3M | $115.8M | $97.71M | $92.11M | $104.5M | $101.7M | $84.03M | $76.12M |
| Accounts Payable | $16.50M | $14.40M | $13.48M | $10.98M | $14.26M | $12.14M | $4.87M | $4.17M |
| Short-Term Debt | $11.84M | $8.82M | $11.81M | $8.79M | $2.78M | $2.77M | -- | $0 |
| **Total Current Liabilities** | $54.09M | $45.12M | $44.18M | $38.49M | $44.18M | $38.60M | $25.35M | $19.95M |
| Long-Term Debt | $11.23M | $19.08M | $18.94M | $21.77M | $27.59M | $27.41M | $29.99M | $29.81M |
| Other Non-Current Liabilities | $4.01M | $3.94M | $3.54M | $5.24M | $3.94M | $4.27M | $4.15M | $1.83M |
| **Total Non-Current Liabilities** | $16.25M | $24.10M | $22.92M | $27.47M | $37.20M | $39.12M | $34.23M | $31.75M |
| **Total Liabilities** | $70.35M | $69.22M | $67.09M | $65.96M | $81.38M | $77.72M | $59.58M | $51.70M |
| **Total Debt (incl. Leases)** | $24.33M | $29.23M | $31.26M | $31.08M | $30.88M | $30.69M | $30.16M | $29.99M |
| Common Stock | $29K | $28K | $27K | $27K | $27K | $27K | $27K | $27K |
| Retained Earnings | -$64.11M | -$99.36M | -$110.9M | -$112.5M | -$114.0M | -$112.0M | -$109.5M | -$107.9M |
| **Total Stockholders' Equity** | $86.92M | $46.59M | $30.61M | $26.15M | $23.13M | $23.96M | $24.45M | $24.43M |
| Total Equity | $86.92M | $46.59M | $30.61M | $26.15M | $23.13M | $23.96M | $24.45M | $24.43M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.60M | -$3.82M | -$936K | -$9.02M | -$1.96M | -$27.97M | -$18.32M | -$12.74M |
| Depreciation & Amortization | $4.04M | $1.15M | $901K | $66K | $155K | $347K | $283K | $63K |
| Stock-Based Compensation | $5.51M | $3.17M | $3.14M | $4.22M | $3.38M | $2.58M | $1.89M | $1.85M |
| Change in Receivables | -$6.40M | -$3.12M | -$1.56M | $3.62M | -$5.42M | $425K | -$473K | -- |
| Change in Inventory | -$5.88M | -$1.84M | -$369K | -$7.0K | $692K | -$862K | -$380K | -- |
| Change in Payables | $6.81M | $2.32M | $53K | -$8.0K | -$570K | $1.77M | -$377K | $413K |
| **Operating Cash Flow** | $10.52M | $969K | $6.82M | $4.82M | -$4.72M | -$22.35M | -$18.03M | -$8.14M |
| Capital Expenditure | -$333K | -$26K | $0 | -$38K | -$9.0K | -$50K | -$1.10M | -$236K |
| **Free Cash Flow** | $10.19M | $943K | $6.82M | $4.78M | -$4.73M | -$22.40M | -$19.12M | -$8.38M |
| **Investing Cash Flow** | -$333K | -$40.01M | -$775K | -$2.79M | -$2.56M | -$50K | -$1.85M | -$236K |
| Common Stock Issued | -- | -- | -- | -- | -- | $28.78M | $453K | -- |
| **Financing Cash Flow** | $815K | $32.59M | -$957K | -$134K | $391K | $31.62M | $5.20M | $21.96M |
| **Net Change in Cash** | $11.01M | -$6.45M | $5.08M | $1.90M | -$6.89M | $9.23M | -$14.67M | $13.58M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $35.25M | $11.58M | $1.55M | $1.48M | -$1.93M | -$2.58M | -$1.57M | -$598K |
| Depreciation & Amortization | $1.44M | $1.39M | $1.13M | $1.02M | $1.01M | $1.00M | $1.01M | $355K |
| Stock-Based Compensation | $3.31M | $1.47M | $1.52M | $1.12M | $1.09M | $2.10M | $1.20M | $782K |
| Change in Receivables | -$1.60M | -$11.48M | -$1.65M | $1.32M | $1.37M | $1.95M | -$11.04M | -$939K |
| Change in Inventory | -$1.35M | $3.32M | $1.41M | -$244K | $5.39M | -$11.38M | $358K | -$812K |
| Change in Payables | $2.09M | $921K | $2.51M | -$3.28M | $2.12M | $7.26M | $705K | $1.48M |
| **Operating Cash Flow** | $35.24M | $7.25M | $7.41M | -$11.55M | $12.03M | $7.96M | $2.09M | -$765K |
| Capital Expenditure | -$13K | $5.0K | -$75K | -$49K | -$284K | $0 | $0 | -$12K |
| **Free Cash Flow** | $35.23M | $7.26M | $7.33M | -$11.60M | $11.74M | $7.96M | $2.09M | -$777K |
| **Investing Cash Flow** | -$3.24M | $5.0K | -$15.07M | -$49K | -$284K | $0 | $0 | -$38.13M |
| **Financing Cash Flow** | -$3.22M | -$76K | $1.39M | $421K | $0 | $0 | $394K | $33.57M |
| **Net Change in Cash** | $28.78M | $7.18M | -$6.28M | -$11.18M | $11.74M | $7.96M | $2.48M | -$5.33M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 53.5% | 60.0% | 66.6% | 67.4% | 87.1% | -1017.9% | 52.8% | -- |
| **Operating Margin** | -1.1% | -6.7% | -3.8% | -38.9% | -6.8% | -69515.4% | -1939.6% | -- |
| **Net Profit Margin** | -5.8% | -9.8% | -3.0% | -42.4% | -9.0% | -71717.9% | -1910.3% | -- |
| Return on Equity (ROE) | -17.6% | -15.7% | -6.0% | -69.0% | -11.1% | -158.7% | -173.6% | -48.4% |
| Return on Assets (ROA) | -5.0% | -5.0% | -2.9% | -36.0% | -7.1% | -106.3% | -107.3% | -45.0% |
| Current Ratio | 1.57x | 2.06x | 1.65x | 3.10x | 5.18x | 6.51x | 7.65x | 13.59x |
| Quick Ratio | 1.17x | 1.29x | 1.60x | 3.01x | 5.06x | 6.18x | 7.45x | 13.21x |
| Debt to Equity | 1.19x | 1.23x | 0.35x | 0.43x | 0.30x | 0.38x | 0.43x | -- |
| **Revenue Growth (YoY)** | +104.9% | +23.3% | +48.9% | -2.7% | +55879.5% | -95.9% | -- | -- |
| Gross Profit Growth (YoY) | +82.6% | +11.2% | +47.1% | -24.7% | -- | -178.5% | -- | -- |
| Operating Cash Flow Growth (YoY) | +986.1% | -85.8% | +41.4% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | +980.7% | -86.2% | +42.5% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +159967.9% | +2690.1% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 69.2% | 57.9% | 54.8% | 53.5% | 51.4% | 59.4% | 58.5% | 60.0% |
| **Operating Margin** | 28.8% | 15.4% | 2.3% | -1.1% | -3.8% | -1.4% | -4.7% | -6.7% |
| **Net Profit Margin** | 35.3% | 12.0% | -1.7% | -5.8% | -9.5% | -7.1% | -9.5% | -9.8% |
| Return on Equity (ROE) | 57.4% | 27.2% | -4.8% | -17.6% | -28.9% | -17.2% | -18.7% | -15.7% |
| Return on Assets (ROA) | 31.7% | 11.0% | -1.5% | -5.0% | -6.4% | -4.1% | -5.5% | -5.0% |
| Current Ratio | 1.79x | 1.52x | 1.21x | 1.57x | 1.63x | 1.77x | 1.97x | 2.06x |
| Quick Ratio | 1.58x | 1.30x | 0.88x | 1.17x | 1.25x | 1.16x | 1.43x | 1.29x |
| Debt to Equity | 0.28x | 0.63x | 1.02x | 1.19x | 1.34x | 1.28x | 1.23x | 1.23x |
| **Revenue Growth (YoY)** | +157.9% | +98.6% | +40.4% | +82.7% | +117.5% | +108.6% | +116.9% | +59.3% |
| Gross Profit Growth (YoY) | +464.0% | +113.1% | +49.4% | +102.3% | +24.6% | +111.9% | +96.9% | +78.4% |
| Operating Income Growth (YoY) | -- | -- | -- | +291.7% | -367.8% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -407.3% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -450.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +193.0% | -8.8% | +254.3% | -- | +307.4% | +534.2% | -- | -297.7% |
| Free Cash Flow Growth (YoY) | +200.0% | -8.8% | +250.7% | -- | +297.8% | +534.2% | -- | -300.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
